spacer
home > white papers > Choosing the Right CMO for HPAPI Manufacturing - AMRI
WHITE PAPERS
logo_AMRI4.jpg

AMRI

phone +1 1-518-512-2000
email info@amriglobal.com
web http://www.amriglobal.com
email 26 Corporate Circle, PO box 15098, Albany NY

Choosing the Right CMO for HPAPI Manufacturing

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) has announced the completion of its acquisition of Sherpa Clinical Packaging (Sherpa).
More info >>


White Papers

Using Device Strategy to Drive R&D Productivity

Phillips-Medisize


More info >>


Industry Events

CPhI & P-MEC India 2018

12-14 December 2018, India Expo Mart, New Delhi, India

CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part of Informa PLC) – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement